We are live on
!
Find out more
ARM
Adirondack Research & Management Portfolio holdings
AUM
$82.2M
1-Year Est. Return
63.78%
This Fund
S&P 500
This Quarter
Est. Return
-3.62%
1 Year Est. Return
+63.78%
3 Year Est. Return
+47.81%
5 Year Est. Return
+101.13%
10 Year Est. Return
–
AUM
$249M
AUM Growth
-$5.33M
(-2.1%)
Cap. Flow
+$10M
Cap. Flow
% of AUM
4.02%
Top 10 Holdings %
Top 10 Hldgs %
23.81%
Holding
120
New
12
Increased
33
Reduced
42
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adtran
ADTN
|
+$5.17M |
| 2 |
Donnelley Financial Solutions
DFIN
|
+$4.94M |
| 3 |
CNO Financial Group
CNO
|
+$3.67M |
| 4 |
Ciena
CIEN
|
+$3M |
| 5 |
HZN
Horizon Global Corporation
HZN
|
+$2.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VSTO
Vista Outdoor Inc.
VSTO
|
+$4.05M |
| 2 |
Stoneridge
SRI
|
+$3.37M |
| 3 |
Performance Food Group
PFGC
|
+$2.6M |
| 4 |
ACH
Accendra Health
ACH
|
+$2.48M |
| 5 |
CALY
Callaway Golf Company
CALY
|
+$2.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.94% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Financials | 14.53% |
| 4 | Industrials | 12.86% |
| 5 | Healthcare | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Pfizer
PFE
$143B
| $319K | 0.13% |
9,470
-2,741
| -22% | -$94.2K |
|
|
IPAS
102
DELISTED
Ipass Inc Common Stock
IPAS
| $310K | 0.12% |
81,474
-31,262
| -28% | -$140K |
|
103
Coca-Cola Europacific Partners
CCEP
$47.8B
| $284K | 0.11% |
6,810
-5,490
| -45% | -$216K |
|
|
GCP
104
DELISTED
GCP Applied Technologies Inc.
GCP
| $256K | 0.1% |
8,815
| – | – |
|
105
US Foods
USFD
$21.9B
| $254K | 0.1% |
7,755
-7,970
| -51% | -$260K |
|
106
Alcoa
AA
$11.8B
| $231K | 0.09% |
5,128
| – | – |
|
107
Crawford & Co Class A
CRD.A
$552M
| $230K | 0.09% |
28,738
+6
| +0% | +$50 |
|
|
CSR
108
Centerspace
CSR
$932M
| $192K | 0.08% |
+3,690
| New | +$192K |
|
|
RNWK
109
DELISTED
RealNetworks Inc
RNWK
| $163K | 0.07% |
53,155
-19,664
| -27% | -$61.9K |
|
110
Ceco Environmental
CECO
$3.99B
| $99K | 0.04% |
22,302
| – | – |
|
|
OIG
111
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
| $31K | 0.01% |
+297
| New | +$32.8K |
|
112
AbbVie
ABBV
$433B
| – | – |
-4,100
| Closed | -$397K |
|
113
Axcelis
ACLS
$4.03B
| – | – |
-5,600
| Closed | -$161K |
|
114
CTS Corp
CTS
$1.86B
| – | – |
-63,786
| Closed | -$1.64M |
|
115
Gaia
GAIA
$47.3M
| – | – |
-127,796
| Closed | -$1.58M |
|
116
Johnson & Johnson
JNJ
$613B
| – | – |
-2,298
| Closed | -$321K |
|
|
KLXI
117
DELISTED
KLX Inc.
KLXI
| – | – |
-9,921
| Closed | -$571K |
|
|
VSTO
118
DELISTED
Vista Outdoor Inc.
VSTO
| – | – |
-278,128
| Closed | -$4.05M |
|
Similar funds
WGA
CAM
BRCA
CIM
SCC
TG
RCIM
MRCP
Adirondack Research & Management's Q1 2018 Portfolio in Review
As of Q1 2018, Adirondack Research & Management held 120 positions worth $249M, down 2.1% from $255M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Adirondack Research & Management deployed $10M of net new capital in Q1 2018, opening 12 new positions and adding to 33 existing holdings. Its largest new stake was Adtran: 309,814 shares worth $4.82M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Stoneridge, an estimated $3.37M trimmed.
- Adirondack Research & Management's largest Q1 2018 buy was Adtran: 309,814 shares worth $4.82M.
- Adirondack Research & Management added most to Ciena in Q1 2018, an estimated $3M increase.
- Adirondack Research & Management's biggest Q1 2018 reduction was Stoneridge, cutting an estimated $3.37M.
- Adirondack Research & Management fully exited Vista Outdoor Inc. in Q1 2018, selling an estimated $4.05M.
- Adirondack Research & Management's ten largest holdings make up 24% of its $249M portfolio in Q1 2018.
- Adirondack Research & Management opened 12 new positions and closed 8 in Q1 2018.
- Adirondack Research & Management's portfolio value fell 2.1% quarter-over-quarter to $249M.
Based on Adirondack Research & Management's 13F filing for Q1 2018, filed 14 May 2018.